Maynard Um
-
-
-
-
-
-
-
Schrodinger (SDGR) PT Lowered to $24 at BMO Capital
-
-
-
-
-
-
-
BofA Securities Upgrades Schrodinger (SDGR) to Buy
-
-
-
-
-
-
-
Schrodinger Inc. (SDGR) Tops Q2 EPS by 15c, provides outlook
-
-
-
-
-
-
-
Schrodinger Inc. (SDGR) Issues Statement Regarding FDA Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs
-
-
-
-
-
-
-
Schrodinger (SDGR) PT Raised to $28 at BMO Capital
-
-
-
-
-
-
435,596 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

